Organon & Co. (OGN)
Pharmaceutical Preparations · Healthcare · $3.5B
Intrinsic Value (Consensus)
$9.40
Current Price
$13.42
Margin of Safety
-30%
30% Above Intrinsic Value
Value: $9
Price: $13
Valuation Model Estimates
Current Price: $13.42
DCF (Discounted Cash Flow)
$25.97
Graham Number
$6.81
Earnings Power Value
$6.99
Relative Value (P/E)
$14.40
Dividend Discount Model
$0.24
Consensus Value
$9.40
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
45
Profitability
22/25
Strength
12/25
Valuation
7/25
Growth
4/25
Financial Health Signals
Very high debt — Debt/Equity ratio is 1149% (above 200% is risky)
Declining revenue — top line is shrinking
Strong profitability — ROE of 25% (above 20% is excellent)
High free cash flow yield (15.3%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $0.72
- EPS (Forward)
- $0.73
- Book Value
- $2.86
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 24.9%
- Debt/Equity
- 1149%
- Revenue Growth
- -2.9%
- Earnings Growth
- 2.0%
- Dividend Yield
- 0.1%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance